To prove that a dataset is sufficiently anonymized, many privacy policies suggest that a re-identification risk assessment be performed, but do not provide a precise methodology for doing so, leaving ...
Artificial intelligence (AI) is emerging as a transformative tool in drug discovery and development, influencing steps from target identification to clinical trial outcome analyses. Target ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results